Presented
by

Presented by Oxford Global

Discover PLUS Pass

All Biologics Content

Bringing you the latest research in Proteins and Antibodies, Peptides, and Oligonucleotides through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Industry Spotlight
FDA's AI Model Enhances Safety of Biosimilar Therapeutic Proteins
Thanks to the FDA's new AI-powered imaging tool, the safety profile of newly developed biosimilar therapeutic protiens may improve.
Edited by Cara Digby-Patel |
28 March 2023
Biosimilars & Biobetters
Industry Spotlight
Biocon’s Biosimilar Difficulties: Successive FDA Rejections Don’t Inspire Hope
Biocon suffer another FDA rejection due to data and manufacturing concerns, this time for their bevacizumab biosimilar.
Edited by Cara Digby-Patel |
15 February 2023
Biosimilars & Biobetters
Industry Spotlight
Retinal Disease Drug Receives Approval from European Commission
Ranivisio is a biosimilar of Lucentis which treats serious retinal diseases.
Edited by Tia Byer |
07 September 2022
Biosimilars & Biobetters
Whitepaper
Biosimilar Structural Comparison of Commercially Sourced Reference Standards by MMS Rapidly Detects Subtle but Critical Differences to Correctly Predict Activity for Use in an ELISA Product
22 March 2022
Biosimilars & Biobetters
Whitepaper
Biosimilar Structural Comparison of Commercially Sourced Reference Standards
06 September 2021
Biosimilars & Biobetters

Search by Keyword

Filter by Subject Area

Biologics Series – Subjects

Filter by Content Type

Resource Formats (incl. Industry Spotlight)

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.